Geraldine Gueron
Proteomics is the study of proteins in a cell and their interactions with each other. The overall goal of this research is to use proteomics for the identification of predictive...Read More
Lauren Harshman
Immunotherapy has come of age with the approval of Sipuleucel-T (Provenge) and the introduction of ipilimumab (Yervoy) and other similar immune modulators into clinical trials for advanced metastatic prostate cancer....Read More
Emmanuel Antonarakis
Understanding resistance to new treatments for advanced, metastatic prostate cancer represents an unmet medical need. Dr. Antonarakis is studying genetic variants of the target of these new medicines as one...Read More
Syed Adnan Ali
Over 1 million prostate biopsies are performed annually in the United States annually while only a quarter present with cancer. Most of these biopsy procedures are triggered by abnormal PSA...Read More
Shuang Zhao, MD
Long non-coding RNAs (lncRNAs) such as PCAT1 and SChLAP1 have emerged as key molecular drivers, biomarkers, and potential therapeutic targets in aggressive prostate cancer. Currently only a small number of...Read More
Rendong Yang
Next generation sequencing (NGS) is a growing class of innovative new gene sequencing techniques that can sequence millions of fragments of DNA simultaneously. NGS results expand our understanding of complex...Read More
Adam Sowalsky
Genomic analysis of cancer tissue has enabled investigators to study mechanisms of resistance to the androgen receptor (AR) inhibitor Xtandi® in men with prostate cancer. Dr. Adam Sowalsky will use...Read More
Prasanna Sooriakumaran
As life expectancy rises, greater numbers of older men with skeletal metastases from prostate cancer suffer higher treatment burdens. The current standard-of-care, androgen deprivation therapy (ADT), causes morbidity and might...Read More
Shabnam Shalapour
Cancer is characterized by accumulation and loss of normal cellular regulatory processes, leading to expression of tumor-specific molecules (antigens). The tumor microenvironment also causes exhaustion of the patient’s immune response...Read More
Michael Schweizer, MD
Dr. Michael Schweizer is an Assistant Professor at the Department of Medicine at the Division of Medical Oncology at the University of Washington School of Medicine. He also is a...Read More